{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T01:46:58Z","timestamp":1792633618727,"version":"4.5.0"},"reference-count":71,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2019,1,24]],"date-time":"2019-01-24T00:00:00Z","timestamp":1548288000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["104\u20132314-B-182A-101-MY3"],"award-info":[{"award-number":["104\u20132314-B-182A-101-MY3"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011892","name":"Kaohsiung Chang Gung Memorial Hospital","doi-asserted-by":"publisher","award":["CMRPG8F0871"],"award-info":[{"award-number":["CMRPG8F0871"]}],"id":[{"id":"10.13039\/501100011892","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011892","name":"Kaohsiung Chang Gung Memorial Hospital","doi-asserted-by":"publisher","award":["CMRPG8C0763"],"award-info":[{"award-number":["CMRPG8C0763"]}],"id":[{"id":"10.13039\/501100011892","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Toxins"],"abstract":"<jats:p>Clinical usage of botulinum neurotoxin (BoNT) in ophthalmology has dramatically increased since the 1980s and has become one of the most widely used agents for treating facial movement disorders, autonomic dysfunction and aesthetic wrinkles. Despite its high efficacy, there are some complications with periocular BoNT injections due to its chemodenervation effect. Among these, there is still controversy over the BoNT effect on tear film homeostasis and the ocular surface. A periocular BoNT injection could dry the eye by reducing tear production of the lacrimal gland and increase tear evaporation due to potential eyelid malposition and abnormal blinks. On the contrary, the injection of BoNT in the medial eyelids could treat dry eye disease by impairing lacrimal drainage. Regarding the ocular surface change, corneal astigmatism and high-order aberrations may decrease due to less eyelid tension. In conclusion, the entire awareness of the effect of BoNT and the patients\u2019 ocular condition is crucial for successful and safe results.<\/jats:p>","DOI":"10.3390\/toxins11020066","type":"journal-article","created":{"date-parts":[[2019,1,24]],"date-time":"2019-01-24T11:12:48Z","timestamp":1548328368000},"page":"66","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["A Review of Periocular Botulinum Neurotoxin on the Tear Film Homeostasis and the Ocular Surface Change"],"prefix":"10.3390","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5475-9800","authenticated-orcid":false,"given":"Ren-Wen","family":"Ho","sequence":"first","affiliation":[{"name":"Department of Ophthalmology, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung 33302, Taiwan"},{"name":"Graduate Institute of Clinical Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung 80708, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Po-Chiung","family":"Fang","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung 33302, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng-Hsien","family":"Chang","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, China Medical University Hospital, China Medical University, Taichung 40402, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4159-0564","authenticated-orcid":false,"given":"Yu-Peng","family":"Liu","sequence":"additional","affiliation":[{"name":"Graduate Institute of Clinical Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung 80708, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Tse","family":"Kuo","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung 33302, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2019,1,24]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/S0161-6420(80)35127-0","article-title":"Botulinum toxin injection into extraocular muscles as an alternative to strabismus surgery","volume":"87","author":"Scott","year":"1980","journal-title":"Ophthalmology"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1001\/archopht.1985.01050030043017","article-title":"Botulinum A toxin injection as a treatment for blepharospasm","volume":"103","author":"Scott","year":"1985","journal-title":"Arch. Ophthalmol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/S0161-6420(87)33337-8","article-title":"Use of botulinum toxin in the treatment of one hundred patients with facial dyskinesias","volume":"94","author":"Mauriello","year":"1987","journal-title":"Ophthalmology"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1136\/jnnp.65.1.111","article-title":"Botulinum toxin treatment of synkinesia and hyperlacrimation after facial palsy","volume":"65","author":"Boroojerdi","year":"1998","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1S","DOI":"10.1097\/01.PRS.0000144795.76040.D3","article-title":"Consensus recommendations on the use of botulinum toxin type a in facial aesthetics","volume":"114","author":"Carruthers","year":"2004","journal-title":"Plast. Reconstr. Surg."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1136\/jnnp.2003.034702","article-title":"Botulinum toxin in clinical practice","volume":"75","author":"Jankovic","year":"2004","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S0300-9084(00)00216-9","article-title":"How botulinum and tetanus neurotoxins block neurotransmitter release","volume":"82","author":"Humeau","year":"2000","journal-title":"Biochimie"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.jtos.2017.05.008","article-title":"TFOS DEWS II Definition and Classification Report","volume":"15","author":"Craig","year":"2017","journal-title":"Ocul. Surf."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1167\/iovs.05-0380","article-title":"Botulinum toxin B-induced mouse model of keratoconjunctivitis sicca","volume":"47","author":"Rizen","year":"2006","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1097\/IOP.0b013e31826e8a86","article-title":"Intraglandular injection of botulinum toxin a reduces tear production in rabbits","volume":"29","author":"Demetriades","year":"2013","journal-title":"Ophthalmic Plast. Reconstr. Surg."},{"key":"ref_11","first-page":"2222","article-title":"Lacrimal gland inflammatory cytokine gene expression in the botulinum toxin B-induced murine dry eye model","volume":"13","author":"Park","year":"2007","journal-title":"Mol. Vis."},{"key":"ref_12","first-page":"250","article-title":"Inflammatory cytokine expression on the ocular surface in the Botulium toxin B induced murine dry eye model","volume":"15","author":"Zhu","year":"2009","journal-title":"Mol. Vis."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1097\/SCS.0b013e31829ac655","article-title":"Functional and histologic changes in the lacrimal gland after botulinum toxin injection","volume":"24","author":"Kim","year":"2013","journal-title":"J. Craniofac. Surg."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.preteyeres.2009.04.003","article-title":"Neural regulation of lacrimal gland secretory processes: Relevance in dry eye diseases","volume":"28","author":"Dartt","year":"2009","journal-title":"Prog. Retin. Eye Res."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.1016\/S0161-6420(99)90534-1","article-title":"Successful treatment of crocodile tears by injection of botulinum toxin into the lacrimal gland: A case report","volume":"106","author":"Riemann","year":"1999","journal-title":"Ophthalmology"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1097\/00002341-200007000-00007","article-title":"Treatment of Frey\u2019s syndrome (gustatory sweating) and \u2018crocodile tears\u2019 (gustatory epiphora) with purified botulinum toxin","volume":"16","author":"Hofmann","year":"2000","journal-title":"Ophthalmic Plast. Reconstr. Surg."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1136\/bjo.86.1.43","article-title":"Botulinum toxin treatment for hyperlacrimation secondary to aberrant regenerated seventh nerve palsy or salivary gland transplantation","volume":"86","author":"Keegan","year":"2002","journal-title":"Br. J. Ophthalmol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1038\/sj.eye.6700230","article-title":"Treatment of gustatory hyperlacrimation (crocodile tears) with injection of botulinum toxin into the lacrimal gland","volume":"16","author":"Montoya","year":"2002","journal-title":"Eye (Lond.)"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1097\/01.iop.0000244515.07925.99","article-title":"Duration of botulinum toxin effect in the treatment of crocodile tears","volume":"22","author":"Boullosa","year":"2006","journal-title":"Ophthalmic Plast. Reconstr. Surg."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1111\/j.1600-0404.2006.00746.x","article-title":"Low-dose subcutaneous injection of botulinum toxin type A for facial synkinesis and hyperlacrimation","volume":"115","author":"Ito","year":"2007","journal-title":"Acta Neurol. Scand."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.jfo.2017.11.010","article-title":"Botulinum neurotoxin A injection for the treatment of epiphora with patent lacrymal ducts","volume":"41","author":"Girard","year":"2018","journal-title":"J. Fr. Ophtalmol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1076\/orbi.22.3.193.15622","article-title":"The use of botulinum toxin A in the treatment of functional epiphora","volume":"22","author":"Whittaker","year":"2003","journal-title":"Orbit"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1016\/j.ophtha.2005.02.022","article-title":"Botulinum toxin for palliative treatment of epiphora in a patient with canalicular obstruction","volume":"112","author":"Tu","year":"2005","journal-title":"Ophthalmology"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1097\/IOP.0b013e318201d1d3","article-title":"Results of lacrimal gland botulinum toxin injection for epiphora in lacrimal obstruction and gustatory tearing","volume":"27","author":"Wojno","year":"2011","journal-title":"Ophthalmic Plast. Reconstr. Surg."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"e75","DOI":"10.3928\/01913913-20141120-02","article-title":"Botulinum toxin injection into the lacrimal gland for treatment of proximal nasolacrimal duct obstructions in children","volume":"51","author":"Eustis","year":"2014","journal-title":"J. Pediatr. Ophthalmol. Strabismus"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1038\/eye.2015.18","article-title":"Botulinum toxin injection for the treatment of epiphora in lacrimal outflow obstruction","volume":"29","author":"Ziahosseini","year":"2015","journal-title":"Eye (Lond.)"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1038\/eye.2016.88","article-title":"Comparison of botulinum toxin-A injection in lacrimal gland and conjunctivodacryocystorhinostomy for treatment of epiphora due to proximal lacrimal system obstruction","volume":"30","author":"Kaynak","year":"2016","journal-title":"Eye (Lond.)"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.jfo.2017.03.006","article-title":"Botulinum neurotoxin injection for the treatment of epiphora in nasolacrimal duct obstruction","volume":"40","author":"Girard","year":"2017","journal-title":"J. Fr. Ophtalmol."},{"key":"ref_29","first-page":"149","article-title":"Decreased tear expression with an abnormal Schirmer\u2019s test following botulinum toxin type A for the treatment of lateral canthal rhytides","volume":"28","author":"Matarasso","year":"2002","journal-title":"Dermatol. Surg."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1097\/IOP.0b013e31802dfca7","article-title":"Effect of botulinum toxin type a on tear production after treatment of lateral canthal rhytids","volume":"23","author":"Arat","year":"2007","journal-title":"Ophthal. Plast. Reconstr. Surg."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1001\/jamaophthalmol.2013.6243","article-title":"Botulinum toxin type a injection for lateral canthal rhytids: Effect on tear film stability and tear production","volume":"132","author":"Ho","year":"2014","journal-title":"JAMA Ophthalmol."},{"key":"ref_32","first-page":"1515","article-title":"Dry eyes and superficial punctate keratitis: A complication of treatment of glabelar dynamic rhytides with botulinum exotoxin A","volume":"30","author":"Northington","year":"2004","journal-title":"Dermatol. Surg."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1001\/archderm.140.11.1351","article-title":"Effect of volume and concentration on the diffusion of botulinum exotoxin A","volume":"140","author":"Hsu","year":"2004","journal-title":"Arch. Dermatol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1007\/s00702-007-0768-7","article-title":"Botulinum toxin in the treatment of blepharospasm and hemifacial spasm","volume":"115","author":"Kenney","year":"2008","journal-title":"J. Neural. Transm. (Vienna)"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1136\/jnnp-2014-307821","article-title":"Botulinum toxin and blink rate in patients with blepharospasm and increased blinking","volume":"86","author":"Ferrazzano","year":"2015","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.survophthal.2006.10.003","article-title":"Botulinum toxin in ophthalmology","volume":"52","author":"Dutton","year":"2007","journal-title":"Surv. Ophthalmol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/S0002-9394(14)77954-1","article-title":"The use of botulinum toxin in blepharospasm","volume":"99","author":"Shorr","year":"1985","journal-title":"Am. J. Ophthalmol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1212\/WNL.35.10.1499","article-title":"Blepharospasm, Meige syndrome, and hemifacial spasm: Treatment with botulinum toxin","volume":"35","author":"Mauriello","year":"1985","journal-title":"Neurology"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"8367","DOI":"10.1038\/s41598-018-26750-5","article-title":"Increase lipid tear thickness after botulinum neurotoxin A injection in patients with blepharospasm and hemifacial spasm","volume":"8","author":"Ho","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1111\/ceo.12165","article-title":"Long-term efficacy and safety of botulinum toxin A injections to treat blepharospasm and hemifacial spasm","volume":"42","author":"Ababneh","year":"2014","journal-title":"Clin. Exp. Ophthalmol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1097\/OPX.0b013e31828f09a7","article-title":"Blink rate, incomplete blinks and computer vision syndrome","volume":"90","author":"Portello","year":"2013","journal-title":"Optom. Vis. Sci."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1167\/iovs.10-6997c","article-title":"The international workshop on meibomian gland dysfunction: Report of the subcommittee on anatomy, physiology, and pathophysiology of the meibomian gland","volume":"52","author":"Knop","year":"2011","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1097\/IOP.0b013e31823f2f82","article-title":"Cranial nerve seven palsy and its influence on meibomian gland function","volume":"28","author":"Shah","year":"2012","journal-title":"Ophthalmic Plast. Reconstr. Surg."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"179","DOI":"10.3109\/02713683.2015.1007211","article-title":"Incomplete Blinking May Attribute to the Development of Meibomian Gland Dysfunction","volume":"41","author":"Wan","year":"2016","journal-title":"Curr. Eye Res."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.jcjo.2015.05.012","article-title":"Meibomian gland dysfunction in Graves\u2019 orbitopathy","volume":"50","author":"Kim","year":"2015","journal-title":"Can. J. Ophthalmol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.jtos.2018.06.001","article-title":"Impact of blinking on ocular surface and tear film parameters","volume":"16","author":"Wang","year":"2018","journal-title":"Ocul. Surf."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.clae.2006.12.002","article-title":"Incomplete blinking: Exposure keratopathy, lid wiper epitheliopathy, dry eye, refractive surgery, and dry contact lenses","volume":"30","author":"McMonnies","year":"2007","journal-title":"Cont. Lens. Anterior Eye"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1016\/S0161-6420(88)32977-5","article-title":"Long-term results and complications of botulinum A toxin in the treatment of blepharospasm","volume":"95","author":"Dutton","year":"1988","journal-title":"Ophthalmology"},{"key":"ref_49","first-page":"335","article-title":"Side effects of the use of botulinum toxin for treatment of benign essential blepharospasm and hemifacial spasm","volume":"21","author":"Kalra","year":"1990","journal-title":"Ophthalmic Surg."},{"key":"ref_50","first-page":"133","article-title":"Treatment of blepharospasm and hemifacial spasm with botulinum A toxin: A Canadian multicentre study","volume":"26","author":"Taylor","year":"1991","journal-title":"Can. J. Ophthalmol."},{"key":"ref_51","first-page":"1842","article-title":"Botulinum toxin increases tearing in patients with Sjogren\u2019s syndrome: A preliminary report","volume":"24","author":"Spiera","year":"1997","journal-title":"J. Rheumatol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/S0002-9394(99)00408-0","article-title":"Effect of eyelid botulinum toxin injection on lacrimal drainage","volume":"129","author":"Sahlin","year":"2000","journal-title":"Am. J. Ophthalmol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1159\/000131089","article-title":"Eyelid botulinum toxin injections for the dry eye","volume":"41","author":"Sahlin","year":"2008","journal-title":"Dev. Ophthalmol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"e108","DOI":"10.1111\/aos.12002","article-title":"Tear production and drainage after botulinum toxin A injection in patients with essential blepharospasm","volume":"91","author":"Park","year":"2013","journal-title":"Acta Ophthalmol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"5957812","DOI":"10.1155\/2016\/5957812","article-title":"Comparison of Two Botulinum Neurotoxin A Injection Patterns with or without the Medial Lower Eyelid in the Treatment of Blepharospasm","volume":"2016","author":"Yang","year":"2016","journal-title":"J. Ophthalmol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"61","DOI":"10.4103\/0974-620X.137142","article-title":"Botulinum neurotoxin type A versus punctal plug insertion in the management of dry eye disease","volume":"7","author":"Bukhari","year":"2014","journal-title":"Oman J. Ophthalmol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s40123-017-0079-5","article-title":"Comparison Between Botulinum Toxin A Injection and Lacrimal Punctal Plugs for the Control of Post-LASIK Dry Eye Manifestations: A Prospective Study","volume":"6","author":"Fouda","year":"2017","journal-title":"Ophthalmol. Ther."},{"key":"ref_58","first-page":"e132","article-title":"Paralysis of the orbicularis muscle of the eye using botulinum toxin type A in the treatment for dry eye","volume":"95","year":"2017","journal-title":"Acta Ophthalmol."},{"key":"ref_59","doi-asserted-by":"crossref","unstructured":"(2007). The definition and classification of dry eye disease: Report of the Definition and Classification Subcommittee of the International Dry Eye WorkShop (2007). Ocul. Surf., 5, 75\u201392.","DOI":"10.1016\/S1542-0124(12)70081-2"},{"key":"ref_60","first-page":"39","article-title":"Histochemical demonstration of acetylcholinesterase activity in human Meibomian glands","volume":"40","author":"Perra","year":"1996","journal-title":"Eur. J. Histochem."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1097\/00002341-200203000-00002","article-title":"A histologic analysis and three-dimensional reconstruction of the muscle of Riolan","volume":"18","author":"Lipham","year":"2002","journal-title":"Ophthalmic Plast. Reconstr. Surg."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"830","DOI":"10.5301\/ejo.5000482","article-title":"Ocular surface alterations in blepharospasm patients treated with botulinum toxin A injection","volume":"24","author":"Kocabeyoglu","year":"2014","journal-title":"Eur. J. Ophthalmol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1097\/ICO.0000000000000482","article-title":"Corneal and Tear Film Changes After Botulinum Toxin-A in Blepharospasm or Hemifacial Spasm","volume":"34","author":"Gunes","year":"2015","journal-title":"Cornea"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.ajo.2013.11.014","article-title":"The influence of benign essential blepharospasm on dry eye disease and ocular inflammation","volume":"157","author":"Lu","year":"2014","journal-title":"Am. J. Ophthalmol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1007\/s10384-016-0469-6","article-title":"Changes in ocular higher-order aberrations following botulinum toxin treatment in patients with blepharospasm: BTX improves dry eye in patients with BEB","volume":"60","author":"Isshiki","year":"2016","journal-title":"Jpn. J. Ophthalmol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"131","DOI":"10.3346\/jkms.2006.21.1.131","article-title":"The changes in corneal astigmatism after botulinum toxin-a injection in patients with blepharospasm","volume":"21","author":"Moon","year":"2006","journal-title":"J. Korean Med. Sci."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1001\/archopht.125.12.1610","article-title":"Effect of upper eyelid surgery on corneal topography","volume":"125","author":"Zinkernagel","year":"2007","journal-title":"Arch. Ophthalmol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1001\/archopht.1991.01080030095046","article-title":"Histologic features of human orbicularis oculi treated with botulinum A toxin","volume":"109","author":"Harris","year":"1991","journal-title":"Arch. Ophthalmol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1136\/bjo.87.1.54","article-title":"Botulinum toxin A treatment in patients suffering from blepharospasm and dry eye","volume":"87","author":"Bergloeff","year":"2003","journal-title":"Br. J. Ophthalmol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1097\/00003226-199111000-00010","article-title":"Epidermal growth factor messenger RNA production in human lacrimal gland","volume":"10","author":"Wilson","year":"1991","journal-title":"Cornea"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1167\/iovs.02-0794","article-title":"Signal transduction pathways used by EGF to stimulate protein secretion in rat lacrimal gland","volume":"44","author":"Tepavcevic","year":"2003","journal-title":"Investig. Ophthalmol. Vis. Sci."}],"container-title":["Toxins"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6651\/11\/2\/66\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T12:28:23Z","timestamp":1760185703000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6651\/11\/2\/66"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,24]]},"references-count":71,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2019,2]]}},"alternative-id":["toxins11020066"],"URL":"https:\/\/doi.org\/10.3390\/toxins11020066","relation":{},"ISSN":["2072-6651"],"issn-type":[{"value":"2072-6651","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,24]]}}}